PIERRE FABRE MEDICAMENT

Italy

All drugs from this manufacturer

  • BRAFTOVI

    It is an anticancer drug used to treat adults with melanoma or non-small cell lung cancer (NSCLC) that have a specific BRAF gene mutation and which has spread or cannot be surgically removed. It is also used for colorectal cancer in patients who have already received other anticancer treatments and who have the same BRAF mutation.

    Dosage form: capsules, hard gelatin

    Active substance Dosage
    encorafenib -

    ATC: L01EC03

  • EBVALLO

    Ebvallo is used for the treatment of a rare type of cancer called Epstein-Barr virus-associated post-transplant lymphoproliferative disorder (EBV PTLD) in adult patients and children aged 2 years and older.

    Dosage form: solution for injection

    Active substance Dosage
    tabelecleucel -

    ATC: L01XL09

  • HEMANGIOL

    This medicine is used to treat hemangioma, a mass formed by a tangle of blood vessels on or under the skin (often called a 'strawberry mark'). It is prescribed to children between 5 weeks and 5 months of age when the lesion threatens life or vital functions (such as sight or hearing), is ulcerated and painful, or carries a risk of permanent scarring and deformity.

    Dosage form: solution, oral

    Active substance Dosage
    propranolol -

    ATC: C07AA05

  • JAVLOR

    It is used for the treatment of advanced or metastatic bladder and urinary tract cancer, when a previous platinum-containing therapy has not been effective.

    Dosage form: solution for infusion, concentrate

    Active substance Dosage
    vinflunine -

    ATC: L01CA05

  • MEKTOVI

    Mektovi is an anticancer drug used in adults to treat a type of melanoma or a type of non-small cell lung cancer (NSCLC), provided that the tumor presents a specific BRAF gene mutation and has spread to other parts of the body or is inoperable.

    Dosage form: tablets, film-coated

    Active substance Dosage
    binimetinib -

    ATC: L01EE03

  • NERLYNX

    It is used for the treatment of early-stage breast cancer in patients who are hormone receptor-positive (HR-positive) and HER2 receptor-positive (HER2-positive), and who have already received treatment with trastuzumab.

    Dosage form: tablets, film-coated

    Active substance Dosage
    neratinib -

    ATC: L01EH02

  • OBGEMSA

    It is used to treat the symptoms of an overactive bladder in adults, such as a sudden urge to urinate, the need to urinate more often than normal, and involuntary loss of urine.

    Dosage form: tablets, film-coated

    Active substance Dosage
    vibegron -

    ATC: G04BD15